Open access
Open access
Powered by Google Translator Translator

Archives

Supplement | The role of liver transplantation in acute-on-chronic liver failure.

25 Aug, 2022 | 11:57h | UTC

Homepage: The Role of Liver Transplantation in Acute-on-Chronic Liver Failure – Clinical Liver Disease

Introduction: The Role of Liver Transplantation in Acute-on-Chronic Liver Failure

Identifying the patient with acute-on-chronic liver failure: navigating through multiple definitions

Pretransplant management of the patient with severe acute-on-chronic liver failure

Transplantation in Acute-on-Chronic Liver Failure: Feasibility and Futility

Posttransplant complications in the setting of acute-on-chronic liver failure and considerations regarding immunosuppression

Palliative Care in the Patient With Acute-on-Chronic Liver Failure

PRO: Patients With Acute-on-Chronic Liver Failure Should Receive Priority on the Liver Transplant Waiting List

Con: Patients With Acute-on-Chronic Liver Failure Should Not Receive Priority on the Waiting List

 


Observational study suggests Hydroxychloroquine is associated with increased risk of cardiovascular events compared to Methotrexate in patients with heart failure.

25 Aug, 2022 | 11:56h | UTC

Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Editorial: Hydroxychloroquine: Heart-Throb No More? – Journal of the American College of Cardiology

Commentary: Caution needed with hydroxychloroquine use in older RA patients with heart failure – medwire News

 


Brief Review | New drugs for acute kidney injury.

25 Aug, 2022 | 11:58h | UTC

New drugs for acute kidney injury – Intensive Care Medicine

 


Systematic Review | Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease.

25 Aug, 2022 | 11:55h | UTC

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider – RMD Open

Related: EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.

 


Vasospastic angina: a contemporary review of its pathophysiology, diagnosis and management.

25 Aug, 2022 | 11:53h | UTC

Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management – Heart International

 

Commentary on Twitter

 


Review | Prevention of first decompensation in advanced chronic liver disease.

25 Aug, 2022 | 11:52h | UTC

Prevention of First Decompensation in Advanced Chronic Liver Disease – Clinics in Liver Disease

 

Commentary on Twitter

 


Cohort Study | Analysis of neonatal neurobehavior and developmental outcomes among preterm infants.

25 Aug, 2022 | 11:51h | UTC

Analysis of Neonatal Neurobehavior and Developmental Outcomes Among Preterm Infants – JAMA Network Open

Invited commentary: Neurobehavior in the Neonatal Intensive Care Unit—Window to the Future? – JAMA Network Open

 

Commentary on Twitter

 


Study Commentary | Is the evidence strong for spinal cord stimulation for diabetic neuropathy? Not all experts agree.

25 Aug, 2022 | 11:52h | UTC

Is the Evidence Strong for Spinal Cord Stimulation for Diabetic Neuropathy? Not All Experts Agree – Neurology Today

Original Study: RCT: Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

 


Study Commentary | Digital youth mental health interventions: will the evidence ever catch up?

25 Aug, 2022 | 11:54h | UTC

Digital youth mental health interventions: will the evidence ever catch up? – The Mental Elf

Original Study: Evidence on Digital Mental Health Interventions for Adolescents and Young People: Systematic Overview – JMIR Mental Health

 


Review | Subphenotypes in acute kidney injury.

25 Aug, 2022 | 11:50h | UTC

Subphenotypes in acute kidney injury: a narrative review – Critical Care

 


Observational study suggests frequent aspirin use may reduce the risk of ovarian cancer.

25 Aug, 2022 | 11:49h | UTC

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentaries:

Frequent Aspirin Use Tied to Lower Ovarian Cancer Risk – HealthDay

Frequent Aspirin Use Shows Promise for Preventing Ovarian Cancer in Individuals at Higher Risk – University of Utah

 

Commentary on Twitter

 


RCT | Nivolumab vs. nivolumab plus docetaxel for previously treated advanced or recurrent immune checkpoint inhibitor-naïve non-small-cell lung cancer.

25 Aug, 2022 | 11:48h | UTC

A randomized comparison of nivolumab versus nivolumab + docetaxel for previously treated advanced or recurrent ICI-naïve non-small-cell lung cancer: TORG1630 – Clinical Cancer Research

 


USPSTF Recommendation Statement | Statin use for the primary prevention of cardiovascular disease in adults.

24 Aug, 2022 | 14:21h | UTC

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Editorials:

Statins for Primary Cardiovascular Disease Prevention: Time to Curb Our Enthusiasm – JAMA Internal Medicine

Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already? – JAMA Network Open

Evidence Report: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author Interview: USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults – JAMA

Patient Page: Statins for the Prevention of Cardiovascular Disease – JAMA

Commentary: Latest statins guidance keeps more conservative approach to preventing first stroke or heart attack – CNN

 


RCT | In women at risk of preterm delivery, half dose antenatal Dexamethasone was NOT noninferior compared to full dose Dexamethasone on neonatal outcomes.

24 Aug, 2022 | 14:20h | UTC

Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Non-nutritive sweeteners affect human microbiomes and can alter glycemic responses.

24 Aug, 2022 | 14:17h | UTC

News Release: Non-nutritive sweeteners affect human microbiomes and can alter glycemic responses – Cell Press

Original Study: Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance – Cell

Commentary: Expert reaction to study looking at the effect of non-nutritive sweeteners on human microbiomes and glycaemic levels – Science Media Centre

 

Commentary on Twitter

 


Retrospective Cohort Study | Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19.

24 Aug, 2022 | 14:17h | UTC

Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19 – JAMA Internal Medicine

 

Commentary on Twitter

 


Monkeypox: a clinical update for pediatricians.

24 Aug, 2022 | 14:19h | UTC

Monkeypox: A clinical update for paediatricians – Journal of Pediatrics and Child Health

Related:

Cohort Study | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain.

CDC Report | Epidemiologic and clinical characteristics of Monkeypox cases in the US.

Update on the Monkeypox Outbreak – JAMA

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review – Clinical Infectious Diseases

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series – The BMJ

WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 – New England Journal of Medicine

Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases

 


Long-term results of a RCT | Vasopressin and methylprednisolone did not improve outcomes in patients with in-hospital cardiac arrest.

24 Aug, 2022 | 14:15h | UTC

Effect of vasopressin and methylprednisolone vs. placebo on long-term outcomes in patients with in-hospital cardiac arrest a randomized clinical trial – Resuscitation

Original Study: RCT: Vasopressin + Methylprednisolone increase the likelihood of return of spontaneous circulation compared to placebo in patients with in-hospital cardiac arrest.

 


Retrospective Cohort Study | Association of COVID-19 vs. Influenza with risk of arterial and venous thrombotic events among hospitalized patients.

24 Aug, 2022 | 14:16h | UTC

Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients – JAMA

Commentary: Higher risk of vein blood clots in COVID vs flu patients – CIDRAP

News Release: People with Severe COVID-19 Face Increased Risk of Life-Threatening Blood Clots – Penn Medicine News

 

Commentary on Twitter

 


Guidelines for clinical assessment and management of adult cochlear implantation for single-sided deafness.

24 Aug, 2022 | 14:13h | UTC

American Cochlear Implant Alliance Task Force Guidelines for Clinical Assessment and Management of Adult Cochlear Implantation for Single-Sided Deafness – Ear and Hearing

 


Position Statement | Chronic kidney disease as cardiovascular risk factor in routine clinical practice.

24 Aug, 2022 | 14:14h | UTC

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association – European Journal of Preventive Cardiology (PDF)

 


M-A of randomized trials | Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors.

24 Aug, 2022 | 14:12h | UTC

Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors: A systematic review and meta-analysis of randomized controlled trials – Cancer Medicine

 


Clinical practice guidelines for the management of atopic dermatitis.

24 Aug, 2022 | 14:13h | UTC

English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021 – The Journal of Dermatology

 


Secondary analysis of a RCT | Early rhythm control in patients with atrial fibrillation and high comorbidity burden.

24 Aug, 2022 | 14:11h | UTC

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden – Circulation

 

Commentary on Twitter

 


Systematic Review | Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

24 Aug, 2022 | 14:10h | UTC

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia – Cochrane Library

Summary: The impact of cumulative medications with anticholinergic effects on future adverse clinical outcomes in people with dementia – Cochrane Library

Related:

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Commonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study – JAMA Internal Medicine

How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative

Anticholinergic drugs and risk of dementia: case-control study – The BMJ

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.